Does LENALIDOMIDE Cause Mobility decreased? 225 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 225 reports of Mobility decreased have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.1% of all adverse event reports for LENALIDOMIDE.
225
Reports of Mobility decreased with LENALIDOMIDE
0.1%
of all LENALIDOMIDE reports
11
Deaths
98
Hospitalizations
How Dangerous Is Mobility decreased From LENALIDOMIDE?
Of the 225 reports, 11 (4.9%) resulted in death, 98 (43.6%) required hospitalization, and 3 (1.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 225 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which LENALIDOMIDE Alternatives Have Lower Mobility decreased Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE